Puls Biznesu

Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets using drugs with stem cells. – […]

Forbes- Incredibles

Forbes about Polish start-ups in the coronavirus crisis: „The year 2020 was a big challenge for companies, individual sectors of the economy and probably all of us. In the coming weeks and months of 2021 it will be similar. The condition of start-ups is no exception here. it is easier and … more difficult for […]

Investors’ Zone

According to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: „This year, an exceptionally large group of companies is choosing NewConnect. As many as 63 companies declared their willingness to enter the alternative market, and several more in the following years.” The largest group are companies from the gaming industry. […]

Portal Wrocław

Gazeta Wrocławska wrote about us: „Bioceltix is ​​working on innovative biological medicines used in the treatment of common autoimmune and inflammatory diseases in companion animals. The company from Wrocław has something to fight for. This is indicated by the numbers on the global drug market for atopic dermatitis in dogs. The value of this market […]

Mam Startup – summary 2021

We create at Bioceltix veterinary biological medicines, and in 2020 we announced plans for a stock exchange debut and we obtained a permit from the Main Pharmaceutical Inspector to manufacture veterinary biological drugs. Despite the pandemic, we continue our projects without downtime. You can read about our plans implemented in 2020 and the future ones […]

Bioceltix: Year in Review

2019? It’s been a good year for Bioceltix. A victory in the Start-Up Challenge coupled with participation in accelerator programs as well as several important congresses, conferences and rankings. A lot has happened over the past year and the next 12 months look even more exciting. Want to know what Łukasz Bzdzion thinks of the […]

MamStartup: Innovative veterinary therapies

Mamstartup: Gallant has developed a non invasive method for retrieving stem cells which can be used to treat various ailments – from torn ligaments and joint inflammation to kidney disease. Poles have accomplishments when it comes to utilizing stem cells in animal treatment. PLN 5.1 million – that’s how much the biotech company Bioceltix received […]

A Polish startup wants to improve the way we fight diseases in dogs and cats

Business Insider caught up with Łukasz Bzdzion, founder of the startup Bioceltix, who – together with his team – is developing biopharmaceuticals for dogs, cats and horses. How is his company improving treatments for animals suffering from degenerative joint or autoimmune diseases? Find out in the article below!

My Company Polska: Bioceltix among the 25 best Polish startups

My Company Polska has selected the 25 hottest and best startups – and we’re among them! The stem-cell-based pharmaceuticals, which Bioceltix is developing, are a safer and more effective alternative to traditional chemical-based pharmaceuticals currently on the market. Bioceltix was established in 2016 – with its first funding coming from the StartitFund which is managed […]

Rzeczpospolita: Millions for Polish medicine for horses

Rzczpospolita: The Wroclaw-based biotech, which is working on breakthrough biopharmaceuticals intended for animals, has received additional financing in the amount of 5.1M PLN. Thanks to the grant Bioceltix, a startup, will begin working on a new project aimed at developing a stem-cell-based treatment for horses. More.

NCBR focuses on modern medicine

In the years to come, we are going to see a crop of biotechnology and other projects with global potential. Breakthrough innovations will not happen by accident but will rather result from a pre-programmed process, supported, among others, by the National Centre for Research and Development under the “Fast Track” scheme. Indeed, Bioceltix, a start-up […]

Parkiet: Bioceltix. A Wrocław startup thinks about the stock market

Parkiet: Bioceltix has been developing its own pharmaceuticals since 2016. It is also one of the first companies in Europe to complete a full EMA registration path for a medicinal product that uses mesenchymal stem cells (MSC) as an active substance. The therapies created by Bioceltix are supposed to be a safer alternative to current […]

InCredibles: Bioceltix

Our company is one of six to qualify for InCredibles 2019 being organized by Sebastian Kulczyk. Incredibles is a multi-purpose program that combines an accelerator with mentoring and support for up-and-coming Polish companies from the tech industry. – We place an emphasis on the practical aspect related to creating and running a business. This is […]

Most Creative People in Business #stories | Łukasz Bzdzion – Bioceltix

A year ago, Łukasz Bzdzion, CEO of Bioceltix, was second in the prestigious „Most Creative People in Business” ranking. Today, as the latest edition of the ranking is published, we get introduced to a new lineup of business leaders. We’re keeping our fingers crossed and hope you are too…and while you do that, why not […]

Start with innovations: stem cells in animal treatment 

Radio dla Ciebie: Yesterday (May 27) Łukasz Bzdzion from Bioceltix – the biotech startup that was recently recognized during European Startup Day organized as part of the European Economic Congress in Katowice – talked about utilizing stem cells to treat osteoarthritis in animals. Bioceltix has a chance to become one of the first companies in the world, […]

A revolution in veterinary care that’s made in Poland

Money: Scientists from Wroclaw are working on breakthrough drugs for dogs, horses and cats. They are being supported by experienced investors. The objective is clear: Bioceltix wants to become one of the first companies in the world to register it’s stem-cell-based biopharmaceutical with the European Medicines Agency (EMA).  – the market for veterinary biopharmaceuticals is […]

Bioceltix has the power to change the world

Many biotech startups are spending money from investors and grants by the billions, in an effort to find new ways of treating humans, but some of them have chosen to focus their attention on animals. Bioceltix does business on this developing market of veterinary products. Developing innovative biopharmaceuticals designed to treat ailments commonly experienced by […]

Five life science start-ups that can change the world

We have found ourselves in the ranking of the 5 most promising Polish start-ups prepared by Money.pl! “From those looking for a drug to cure cancer, through manufacturers of at-home lab devices, up to scientists who want to set stem cells to save the lives of animals. Poland seems to be swarming with biotech and telemedicine […]

Łukasz Bzdzion on Radio Wrocław

Łukasz Bzdzion visited Filip Marczyński on Radio Wrocław. The CEO of Bioceltix talked about biological drugs for animals that are currently developed with the use of mesenchymal stem cells, and also about the entire team’s plans for the nearest future. You can listen to the full interview here.

Veterinary biological drugs – Bioceltix summarizes the year 2018

For Bioceltix, last year was filled with new, exciting challenges. From rankings and accelerator programs to contests and even a newly-opened #lab – it’s been a busy time. The ultimate goal remains unchanged – launching innovative biopharmaceuticals for #animals… and we’re getting closer by the day. Read more about what our company has been up […]

Bioceltix is ​​working on drugs based on stem cells for animals [interview]

MamStartup: Bioceltix is a biotech startup that does business in the veterinary industry – the company focuses on developing stem-cell-based biopharmaceuticals.  These biopharmaceuticals are a safer as well as more effective alternative to synthetic drugs, which treat only symptoms, not underlying causes. The aforementioned „synthetics” still remain by far the most popular choice when it […]

Innowacje na start: Chivas Venture and Bioceltix

We hope you had a chance to tune in to „Radio dla Ciebie” during the „Let’s start with Innovation” („Innowacje na start”) show – that’s for coverage of Chivas Ventures. The forth edition of this contest for startups that are socially involved has now come, gone and guess what? The jury liked our biopharmaceutical veterinary […]

Bioceltix has made it to the final round of Chivas Ventures

Another round of the prestigious contest designed for social-involved startups – Chivas Venture–  is behind us. We are among the five companies that, on January 17th 2019, will take part in the grand finale of the contest – which is happening in Warsaw. That mid-January evening will be when we find out which innovative company […]

(Un)limited stem cells

biotechnologia.pl: Poland is among the countries where innovative biopharmaceuticals re being designed to treat household animals. Bioceltix is developing MSC-based medicines for dogs, horses and cats. The biopharmaceuticals, which are made in Poland, utilise the anti-inflammatory and pain-relief properties of Mesenchymal Stem Cells. In contrast to traditional chemical-based pharmaceuticals, the bio-based variants being developed by […]

More startups participating in the MIT Enterprise Forum Poland accelerator program. The technologies they have to offer are full of surprises!

proseedmag: the MIT Enterprise Forum Poland program aims to speed up the development of recently-established tech companies. It accomplishes this by connecting these innovators with the know-how, experience and assets of leading corporations, investment funds as well as various other organizations from Poland and around the world. Nearly 100 startups have already received a much-needed […]

Bioceltix is entering an infant industry

All of the stem-cell-based biopharmaceuticals being developed by our company are designed to treat conditions caused by chronic inflammatory diseases. We are developing biopharmaceuticals to treat osteoporosis and atopic dermatitis in dogs, chronic inflammation of the oral cavity as well as gingivitis in cats, and medicines that help heal torn ligaments and treat conditions related […]

We know the results of the 50 Most Creative Minds in Business ranking

The gala that concluded the 8th edition of this ranking took place on June 27th at Warsaw’s Multikino Złote Tarasy. This time the event was conducted in an entirely new format. It was hosted by Grzegorz Kiszluk, Editor-in-Chief of Brief Magazine as well as award winners from previous years. Łukasz Bzdzion, CEO of our very […]

Bioceltix – Wroclaw start-up awarded. Creates biological drugs for animals

Gazeta Wrocławska: Bioceltix develops biological drugs for common pet diseases. At the moment, the company is working on drugs for locomotor system diseases (osteoarthritis), autoimmune diseases (atopic dermatitis) and various types of cancer. – The products that we create use the analgesic and anti-inflammatory properties of mesenchymal stem cells, which makes them a modern alternative to […]

Residents of Wroclaw are among the most creative contributors to business in 2018

Scientists, experts and entrepreneurs from Wroclaw have been recognized in the Most Creative Minds in Business Ranking published by Brief magazine. As high as second on the prestigious list was Łukasz Bzdzion – the biotechnologist and molecular biologist who is the founder and CEO of Wroclaw-based biotech startup Bioceltix. His company is focused on developing […]

Animals in a medical revolution

Wrocław scientists in the comfort of laboratories are preparing drugs that change the standards of treating dogs, cats and horses. Just a little bit of fat, a lot of capital and a dose of scientific magic – it’s the Puls Biznesu about us! Read more.

The Polish startup creates super modern drugs for animals

As the first company in Europe, Bioceltix intends to authorize a veterinary biopharmaceutical based on stem cells. Łukasz Bzdzion, the CEO of the startup we talked to at the Impact’18 congress, tells about the advantages of Polish technology over those that are currently in use – Business Insdier Polska.

Interview with Łukasz Bzdzion on Impact’18 in Kraków

We was on Impact’18, congress that brings leaders at the forefront of innovation from many sectors together to explore the opportunities for creating global biotechnology future. ImpactCEE is the most important event on the future of the biotechnology and digital economy for the business, startups, scientists and public officials.

WallStreet 22 Conference: Łukasz Bzdzion

CEO of Bioceltix, Łukasz Bzdzion, during the WallStreet conference in Karpacz talked about the AlloMSCs technology, biopharmaceuticals based on stem cells and business model of our company.

The Polish company has created innovative veterinary drugs

– We are the first company in Europe to develop and implement animal-safe and business-scale technology that uses allogeneic stem cells in therapy. Thanks to the use of allogeneic cells, i.e. one donor and many recipients, we have the opportunity to create drugs that will be available immediately, at the clinic, at the veterinarian – […]

Public money drives a white and red technological breakthrough

One of last year’s beneficiaries of Sub-measure 1.1.1 of the Intelligent Development Operational Program 2014-2020 is Bioceltix, a Wroclaw biotechnology start-up, implementing on the world market veterinary biopharmaceuticals based on mesenchymal stem cells (MSC). The technology developed by the Bioceltix team allows the use of allogeneic stem cells in the therapy without the need to […]

Powered by  Zgodności ciasteczek z RODO
Przegląd prywatności

Ta strona korzysta z ciasteczek, aby zapewnić Ci najlepszą możliwą obsługę. Informacje o ciasteczkach są przechowywane w przeglądarce i wykonują funkcje takie jak rozpoznawanie Cię po powrocie na naszą stronę internetową i pomaganie naszemu zespołowi w zrozumieniu, które sekcje witryny są dla Ciebie najbardziej interesujące i przydatne.